Navigation Links
'Second Thoughts about Fluoride,' Reports Scientific American
Date:1/3/2008

NEW YORK, Jan. 2 /PRNewswire-USNewswire/ -- "Some recent studies suggest that over-consumption of fluoride can raise the risks of disorders affecting teeth, bones, the brain and the thyroid gland," reports Scientific American editors (January 2008). "Scientific attitudes toward fluoridation may be starting to shift," writes author Dan Fagin.

"Fluoride, the most consumed drug in the USA, is deliberately added to 2/3 of public water supplies theoretically to reduce tooth decay, but with no scientifically-valid evidence proving safety or effectiveness," says lawyer Paul Beeber, President, New York State Coalition Opposed to Fluoridation.

Fagin, award-wining environmental reporter and Director of New York University's Science, Health and Environmental Reporting Program, writes, "There is no universally accepted optimal level for daily intake of fluoride." Some researchers even wonder whether the 1 mg/L added into drinking water is too much, reports Fagin.

After 3 years of scrutinizing hundreds of studies, a National Research Council (NRC) committee "concluded that fluoride can subtly alter endocrine function, especially in the thyroid -- the gland that produces hormones regulating growth and metabolism," reports Fagin.

Fagin quotes John Doull, professor emeritus of pharmacology and toxicology at the University of Kansas Medical Center, who chaired the NRC committee thusly, "The thyroid changes do worry me."

Fluoride in foods, beverages, medicines and dental products can result in fluoride over-consumption, visible in young children as dental fluorosis -- white spotted, yellow, brown and/or pitted teeth. We can't normally see fluoride's effects to the rest of the body.

Reports Fagin, "a series of epidemiological studies in China have associated high fluoride exposures with lower IQ."

"(E)pidemiological studies and tests on lab animals suggest that high fluoride exposure increases the risk of bone
'/>"/>

SOURCE NYS Coalition Opposed to Fluoridation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Spherix Reports Second Quarter Earnings
2. Tapestry Reports Second Quarter 2007 Results
3. Callisto Reports on Second-Quarter 2007 Milestones
4. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
11. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 2Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 3Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 4Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 5Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 6Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 7Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 8Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 9Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 2Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 3Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 4Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 5Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 6Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 7Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 8Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 9Remote Technologies Improve Patient Care, Viable Alternative to Intensivist Shortage 2Remote Technologies Improve Patient Care, Viable Alternative to Intensivist Shortage 35 Year Study Published in Diabetologia Demonstrated Long Term Safety of Lantus 28R 29 Compared to NPH 4685 15 Year Study Published in Diabetologia Demonstrated Long Term Safety of Lantus 28R 29 Compared to NPH 4685 25 Year Study Published in Diabetologia Demonstrated Long Term Safety of Lantus 28R 29 Compared to NPH 4685 35 Year Study Published in Diabetologia Demonstrated Long Term Safety of Lantus 28R 29 Compared to NPH 4685 45 Year Study Published in Diabetologia Demonstrated Long Term Safety of Lantus 28R 29 Compared to NPH 4685 5Health Integrated Hosts Industry Collaborative Focused on the Patient Centered Medical Home 28PCMH 29 50737 1Health Integrated Hosts Industry Collaborative Focused on the Patient Centered Medical Home 28PCMH 29 50737 2Health Integrated Hosts Industry Collaborative Focused on the Patient Centered Medical Home 28PCMH 29 50737 3NeoStem Inc Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 50735 1NeoStem Inc Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 50735 2NeoStem Inc Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 50735 3NeoStem Inc Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 50735 4
Breaking Medicine News(10 mins):Health News:Beating Heart Differs by Gender, Age: Study 2Health News:Many Dialysis Patients Get Wrong Blood Thinners for Angioplasty 2Health News:Many Dialysis Patients Get Wrong Blood Thinners for Angioplasty 3Health News:Review Questions Tamiflu's Effectiveness 2Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 2Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 3Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 4Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 5Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 6Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 7Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 8Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 9Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 10Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 11Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 12Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 13Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 14Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 15Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 16Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 17Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 18Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 19Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 20Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 21Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 2Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 3Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 4Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 5Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 6Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 7Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 8Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 9Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 10Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 11Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 12
Other Medicine News:Health News:Lung Cancer Alliance Calls American Cancer Society's Claim of Progress Selective 2Health News:Hospital Car Parking Fees Top the List of Life's Biggest Injustices 2Health News:The Pill Kills Women: Largest Protest Against Birth Control Pill 2Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 2Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 3Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 4Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 5Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 6Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 7Health News:Monterey Mushrooms Launches Vitamin D Enriched Sun Grill-A-Bella and White Mushrooms 2Health News:The Female Health Company Switches to the NASDAQ Stock Market 2Health News:The Female Health Company Switches to the NASDAQ Stock Market 3